Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial

Several vaccines have been developed to control the COVID-19 pandemic. CoronaVac(®), an inactivated SARS-CoV-2 vaccine, has demonstrated safety and immunogenicity, preventing severe COVID-19 cases. We investigate the safety and non-inferiority of two immunization schedules of CoronaVac(®) in a non-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abarca, Katia, Iturriaga, Carolina, Urzúa, Marcela, Le Corre, Nicole, Pineda, Augusto, Fernández, Carolina, Domínguez, Angélica, González, Pablo A., Bueno, Susan M., Donato, Paulina, Espinoza, Pilar, Fuentes, Daniela, González, Marcela, Guzmán, Paula, Muñoz-Venturelli, Paula, Pérez, Carlos M., Potin, Marcela, Rojas, Álvaro, González-Aramundiz, José V., Gálvez, Nicolás M. S., Aguirre-Boza, Francisca, Aljaro, Sofía, Bátiz, Luis Federico, Campisto, Yessica, Cepeda, Mariela, Cortés, Aarón, López, Sofía, Pérez, María Loreto, Schilling, Andrea, Kalergis, Alexis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323976/
https://www.ncbi.nlm.nih.gov/pubmed/35891246
http://dx.doi.org/10.3390/vaccines10071082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323976/
https://www.ncbi.nlm.nih.gov/pubmed/35891246
http://dx.doi.org/10.3390/vaccines10071082

Ejemplares similares